ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

DeVita: “The War On Cancer Is Dead”

June 11, 2010

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Editorial: Ambiance Through Exclusion

May 20, 1994

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977